Argan AGX
$268.94 −$26.91 (-9.10%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $276.07 +2.65%
Open$286.43
Prev close$295.85
Day range$263.46 – $287.94
Volume376.8K
Market cap$3.77B
P/E (TTM)21.2
Dividend yield0.74%
Fundamentals
Latest reported quarter: Q2, ended Jul 2026
Revenue$383.98M+61.5% YoY
Operating profit$56.81M+89.0% YoY
Net profit$53.30M+51.1% YoY
Diluted EPS$3.76+50.4% YoY
Free cash flow$91.72M+178.7% YoY
Operating cash flow$96.97M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin20.9%
Operating margin15.4%
Net margin15.1%
Return on equity39.8%
Return on assets15.7%
Return on invested capital39.3%
Current ratio1.50
Liabilities / assets63.8%
Cash & investments$1.03B
Net cash (debt)$1.03B
Free cash flow / sales45.9%
Where the revenue comes from
Quarter 2027/Q2
By business line
Income statement
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $383.98M | $290.95M | $944.61M | $262.05M | $251.15M |
| Total Operating Revenue | $383.98M | $290.95M | $944.61M | $262.05M | $251.15M |
| Cost of Revenue | $309.76M | $229.84M | $750.93M | $196.45M | $204.20M |
| Gross Profit | $74.22M | $61.11M | $193.68M | $65.60M | $46.95M |
| Operating Expense | $17.41M | $15.72M | $58.98M | $17.93M | $14.32M |
| Selling and Admin Expenses | $17.41M | $15.72M | $58.98M | $17.93M | $14.32M |
| Operating Profit | $56.81M | $45.40M | $134.70M | $47.67M | $32.63M |
| Other Income (Expense) | $10.08M | $8.37M | $25.81M | $7.72M | $7.06M |
| Other Non-Operating Income (Expenses) | $10.08M | $8.37M | $25.81M | $7.72M | $7.06M |
| Pretax Profit | $66.89M | $53.77M | $160.51M | $55.39M | $39.69M |
| Tax | $13.59M | $7.71M | $22.74M | $6.18M | $8.96M |
| Net Profit | $53.30M | $46.06M | $137.77M | $49.21M | $30.74M |
| Profit from Continuing Operations | $53.30M | $46.06M | $137.77M | $49.21M | $30.74M |
| Net Income to Parent Company | $53.30M | $46.06M | $137.77M | $49.21M | $30.74M |
| Net Income to Common Stockholders | $53.30M | $46.06M | $137.77M | $49.21M | $30.74M |
| Basic EPS | $3.80 | $3.30 | $10.00 | $3.54 | $2.22 |
| Diluted EPS | $3.76 | $3.24 | $9.74 | $3.47 | $2.17 |
| Dividend Per Share | $0.50 | $0.50 | $1.75 | $0.50 | $0.50 |
Balance sheet
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Total Assets | $1.40B | $1.29B | $1.19B | $1.19B | $1.05B |
| Total Current Assets | $1.32B | $1.22B | $1.13B | $1.13B | $997.17M |
| Cash and Cash Equivalents & Short-Term Investments | $1.03B | $973.56M | $894.98M | $894.98M | $726.82M |
| -Cash and Cash Equivalents | $364.48M | $355.85M | $339.48M | $339.48M | $306.29M |
| -Short Term Investments | $663.97M | $617.71M | $555.50M | $555.50M | $420.53M |
| Receivables | $251.80M | $203.45M | $213.09M | $213.09M | $252.17M |
| -Accounts Receivable | $180.36M | $105.71M | $133.68M | $133.68M | $170.38M |
| -Taxes Receivable | $35.73M | $35.73M | $36.02M | $36.02M | $38.78M |
| -Other Receivables | $35.71M | $62.02M | $43.40M | $43.40M | $38.40M |
| Prepaid Assets | $12.12M | $13.56M | $5.79M | $5.79M | $6.31M |
| Inventory | $13.13M | $12.20M | $10.98M | $10.98M | $6.76M |
| Other Current Assets | $12.98M | $13.35M | $7.42M | $7.42M | $5.11M |
| Total Non-Current Assets | $82.50M | $70.33M | $54.10M | $54.10M | $53.70M |
| Net PPE | $45.80M | $40.92M | $24.61M | $24.61M | $24.13M |
| -Gross PPE | $45.80M | $40.92M | $45.96M | $45.96M | $24.13M |
| Goodwill and Other Intangible Assets | $36.70M | $29.41M | $29.48M | $29.48M | $29.57M |
| -Goodwill | $30.67M | $28.03M | $28.03M | $28.03M | $28.03M |
| -Other Intangible Assets | $6.03M | $1.38M | $1.45M | $1.45M | $1.53M |
| Total Liabilities | $894.13M | $812.93M | $724.09M | $724.09M | $631.16M |
| Total Current Liabilities | $878.11M | $794.69M | $711.26M | $711.26M | $619.86M |
| Payables | $115.21M | $123.85M | $107.54M | $107.54M | $100.80M |
| -Accounts Payable | $115.21M | $123.85M | $107.54M | $107.54M | $100.80M |
| Current Accrued Expenses | $84.72M | $68.55M | $46.50M | $46.50M | $36.47M |
| Short-Term Debt and Capital Lease Obligation | $10.92M | $9.58M | $2.52M | $2.52M | $2.63M |
| -Current Capital Lease Obligation | $10.92M | $9.58M | $2.52M | $2.52M | $2.63M |
| Current Deferred Liabilities | $627.02M | $565.77M | $513.97M | $513.97M | $451.92M |
| Total Non-Current Liabilities | $16.02M | $18.24M | $12.84M | $12.84M | $11.30M |
| Non-Current Deferred Liabilities | $3.06M | $4.91M | $6.56M | $6.56M | $6.12M |
| Other Non-Current Liabilities | $12.96M | $13.33M | $6.28M | $6.28M | $5.18M |
| Total Equity | $506.84M | $473.51M | $462.26M | $462.26M | $419.71M |
| Stockholders' Equity | $506.84M | $473.51M | $462.26M | $462.26M | $419.71M |
| Capital Stock | $2.37M | $2.37M | $2.37M | $2.37M | $2.37M |
| -Common Stock | $2.37M | $2.37M | $2.37M | $2.37M | $2.37M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $165.04M | $163.23M | $167.23M | $167.23M | $167.08M |
| Retained Earnings | $491.54M | $445.26M | $406.20M | $406.20M | $363.96M |
| Less: Treasury Stock | -$144.91M | -$134.97M | -$114.36M | -$114.36M | -$113.59M |
| Gains/Losses Not Affecting Retained Earnings | -$7.20M | -$2.38M | $818,000.00 | $818,000.00 | -$109,000.00 |
| -Notes Receivable | – | – | $0.00 | $0.00 | $4.61M |
| -Accumulated Depreciation | – | – | -$21.34M | -$21.34M | – |
| Non-Current Deferred Assets | – | – | $0.00 | $0.00 | $0.00 |
Cash flow
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $96.97M | $113.38M | $414.72M | $172.33M | $172.49M |
| Net cash flow from continuing operations | $96.97M | $113.38M | $414.72M | $172.33M | $172.49M |
| Net Income from Continuing Operations | $53.30M | $46.06M | $137.77M | $49.21M | $30.74M |
| Depreciation & Depletion & Amortization | $3.51M | $2.18M | $6.17M | $4.76M | -$1.65M |
| Deferred Tax | -$513,000.00 | -$869,000.00 | $6.28M | $559,000.00 | $4.95M |
| Other Non-Cash Items | -$1.44M | -$60,000.00 | -$769,000.00 | -$3.64M | $3.37M |
| Change in Working Capital | $39.69M | $64.03M | $257.39M | $118.88M | $133.22M |
| -Change in Receivables | -$46.03M | $9.35M | $27.29M | $31.71M | -$5.89M |
| -Change in Payables and Accrued Expense | $23.55M | $17.50M | $28.64M | $28.78M | $11.88M |
| -Change in Other Current Assets | $932,000.00 | -$14.63M | -$13.26M | -$3.66M | -$7.87M |
| -Change In Other Working Capital | $61.25M | $51.81M | $214.73M | $62.05M | $135.10M |
| Net cash flow from investing | -$63.26M | -$67.48M | -$182.02M | -$130.63M | -$37.14M |
| Net Cash Flow from Continuing Investing Activities | -$63.26M | -$67.48M | -$182.02M | -$130.63M | -$37.14M |
| Net PPE Purchase and Sale | -$5.26M | -$2.43M | -$3.88M | -$1.21M | -$583,000.00 |
| Net Investment Purchase and Sale | -$50.04M | -$65.05M | -$171.65M | -$134.45M | -$25.03M |
| Financing Cash Flow | -$18.08M | -$33.65M | -$42.59M | -$10.14M | -$7.52M |
| Net Cash Flow from Continuing Financing Activities | -$18.08M | -$33.65M | -$42.59M | -$10.14M | -$7.52M |
| Net Common Stock Issuance | -$6.69M | -$2.96M | -$9.88M | -$2.83M | $0.00 |
| Cash Dividends Paid | -$7.02M | -$7.01M | -$24.28M | -$6.98M | -$7.05M |
| Proceeds from Stock Option Exercised | -$4.37M | -$23.69M | -$8.44M | – | – |
| Ending Cash Balance | $364.48M | $355.85M | $339.48M | $339.48M | $306.29M |
| Net Change in Cash | $15.63M | $12.25M | $190.11M | $31.56M | $127.83M |
| Beginning Cash Balance | $355.85M | $339.48M | $145.26M | $306.29M | $177.85M |
| Effect of Exchange Rate Changes | -$7.00M | $4.11M | $4.11M | $1.63M | $611,000.00 |
| Free Cash Flow | $91.72M | $110.95M | $410.84M | $171.13M | $171.91M |
| Net Business Purchase and Sale | – | – | -$11.52M | $0.00 | -$11.52M |
| Net Other Investing Changes | – | – | $5.02M | – | – |
No comments yet — be the first to weigh in on AGX.
Sign in to join the discussion.